In fact, findings from FMR1 Knockout (FMR1-KO) mice and genetic deletion studies support the hypothesis that aberrant regulation of mGluR5 can lead to developmental synaptic disorders such as FXS or autism spectrum disorder and hence can serve as a target for interventions. The gene discussed is FMR1; the disease is autism spectrum disorder.